Guangdong Transtek Medical Electronics Co.,Ltd.

In response to growing demand for more inclusive health monitoring devices,  Transtek proudly announces the launch of its latest blood pressure monitor, designed specifically to accommodate wider arm circumferences.

In the ever-evolving landscape of health monitoring, the importance of efficient tools for weight management cannot be overstated.

The healthcare industry is full of innovation and new technology. This time we're excited to introduce our latest innovation TeleRPM Scale Gen 2 – a smart scale specifically designed for your patients' weight management needs.

On 9-11 April, 2024, as a pioneering manufacturer and service provider of Remote Patient Monitoring (RPM) devices and solutions, TRANSTEK will exhibit at DMEA taking place on 9-11 April, 2024. The event will be hosted at Berlin.

On 11-15 March 2024, as a pioneering manufacturer and service provider of Remote Patient Monitoring (RPM) devices and solutions, TRANSTEK will exhibit at HIMSS taking place on 11-15 March 2024. The event will be hosted in Orlando.

On 25-28 Feb, 2024, as a pioneering manufacturer and service provider of Remote Patient Monitoring (RPM) devices and solutions, TRANSTEK will exhibit at ViVE taking place on 25-28 Feb, 2024. The event will be hosted at Los Angeles.

Obesity stands as a major global health challenge, contributing to a lot of health issues. In the US, it's estimated that a little over 42% of American adults are obesity, while about 30.7% are overweight. Overall, more than two-thirds of U.S.

On 13-16 Nov, 2023, as a pioneering manufacturer and service provider of Remote Patient Monitoring (RPM) devices and solutions, TRANSTEK will exhibit at Medica taking place on 13-16 Nov, 2023. The event will be hosted at Dusseldorf, Germany.

Haematocrit Correction Technology, often referred to as HCT correction, is a cutting-edge advancement designed to tackle the variability in blood glucose measurements caused by fluctuations in Haematocrit levels.

Diabetes, a chronic medical condition affecting millions of people, patients of Type 1 and 2 diabetes need to regularly monitor and control their blood sugar levels. According to diabetes research, 37.3 million people, or 11.3% of the U.S.